Calithera Biosciences Inc. buy elfe
Start price
08.01.15
/
50%
€407.00
Target price
02.02.15
€640.00
Performance (%)
-14.87%
End price
02.02.15
€346.48
Summary
This prediction ended on 02.02.15 with a price of €346.48. The price of Calithera Biosciences Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.87%. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Calithera Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by elfe for this prediction
In the thread Calithera Biosciences diskutieren
Die Gesellschaft ist auf die Entwicklung niedermolektularer Wirkstoffe gegen Tumorstoffwechsel und Tumorimmologie.
Marktplazierung: 329,21 Millionen Euro
Anzahl der Aktien 17,93 Millionen
Kaufsignal.
http://www.finanzen.net/aktien/Calithera_Biosciences-Aktie
http://tickerreport.com/banking-finance/378743/zacks-analysts-give-average-recommendation-of-buy-to-calithera-biosciences-nasdaqcala/
(Vom Mitglied beendet)


